{
  "name": "DLBCL_Treatment_Round_Two",
  "remarks": [
    "A blank module"
  ],
  "states": {
    "Initial": {
      "type": "Initial",
      "direct_transition": "Second Line Treatment"
    },
    "Terminal": {
      "type": "Terminal"
    },
    "Second Line Treatment": {
      "type": "Simple",
      "direct_transition": "Meet Oncologist for Second-line Treatment Options"
    },
    "Meet Oncologist for Second-line Treatment Options": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "reason": "",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 223484005,
          "display": "Discussion about treatment (procedure)"
        }
      ],
      "direct_transition": "End Meeting with Oncologist"
    },
    "End Meeting with Oncologist": {
      "type": "EncounterEnd",
      "direct_transition": "Interim before Treatment"
    },
    "Interim before Treatment": {
      "type": "Delay",
      "range": {
        "low": 1,
        "high": 7,
        "unit": "days"
      },
      "direct_transition": "Encounter for  Second Line Treatment"
    },
    "R-DHAP": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 2045404,
          "display": "0.005 ML dexamethasone 103.4 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 309311,
          "display": "cisplatin 1 MG/ML Injectable Solution"
        },
        {
          "system": "RxNorm",
          "code": 249364,
          "display": "20 ML cytarabine 100 MG/ML Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "R-ESHAP": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 1734340,
          "display": "etoposide 100 MG Injection"
        },
        {
          "system": "RxNorm",
          "code": 1743779,
          "display": "1 ML methylprednisolone acetate 40 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 249364,
          "display": "20 ML cytarabine 100 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 309311,
          "display": "cisplatin 1 MG/ML Injectable Solution"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "R-GDP": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 2058858,
          "display": "120 ML gemcitabine 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 2045404,
          "display": "0.005 ML dexamethasone 103.4 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 309311,
          "display": "cisplatin 1 MG/ML Injectable Solution"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "R-GemOx": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 2058858,
          "display": "120 ML gemcitabine 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 1736776,
          "display": "10 ML oxaliplatin 5 MG/ML Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "R-ICE": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 1791599,
          "display": "20 ML ifosfamide 50 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 597195,
          "display": "carboplatin 10 MG/ML Injectable Solution"
        },
        {
          "system": "RxNorm",
          "code": 1734340,
          "display": "etoposide 100 MG Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "R-MINE": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 204870,
          "display": "mesna 100 MG/ML Injectable Solution"
        },
        {
          "system": "RxNorm",
          "code": 1791599,
          "display": "20 ML ifosfamide 50 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 197989,
          "display": "mitoxantrone 2 MG/ML Injectable Solution"
        },
        {
          "system": "RxNorm",
          "code": 1734340,
          "display": "etoposide 100 MG Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "Encounter for  Second Line Treatment": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "reason": "",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 185347001,
          "display": "Encounter for problem (procedure)"
        }
      ],
      "distributed_transition": [
        {
          "transition": "Non_candidates_for_Transplant",
          "distribution": 0.5
        },
        {
          "transition": "Patients_with_intention_to_proceed_to_transplant",
          "distribution": 0.5
        }
      ]
    },
    "End Second Line Treatment Encounter": {
      "type": "EncounterEnd",
      "direct_transition": "Wait for PET-CT Scan"
    },
    "Wait for PET-CT Scan": {
      "type": "Delay",
      "direct_transition": "Encounter for PET-CT Scan",
      "range": {
        "low": 1,
        "high": 7,
        "unit": "days"
      }
    },
    "Encounter for PET-CT Scan": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "reason": "",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 185347001,
          "display": "Encounter for problem (procedure)"
        }
      ],
      "direct_transition": "PET-CT Scan"
    },
    "PET-CT Scan": {
      "type": "Procedure",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 450436003,
          "display": "Positron emission tomography with computed tomography (procedure)"
        }
      ],
      "duration": {
        "low": 30,
        "high": 60,
        "unit": "minutes"
      },
      "direct_transition": "End PET-CT Scan Encounter"
    },
    "End PET-CT Scan Encounter": {
      "type": "EncounterEnd",
      "distributed_transition": [
        {
          "transition": "Second Line Treatment Inneffective",
          "distribution": 0.1
        },
        {
          "transition": "Second-Line Treatment Halted Spread of Disease",
          "distribution": 0.9
        }
      ],
      "remarks": [
        "Remission is typically detected at a subsequent follow-up visit"
      ]
    },
    "Patients_with_intention_to_proceed_to_transplant": {
      "type": "Simple",
      "distributed_transition": [
        {
          "transition": "R-DHAP",
          "distribution": 0.25
        },
        {
          "transition": "R-ESHAP",
          "distribution": 0.05
        },
        {
          "transition": "R-GDP",
          "distribution": 0.095
        },
        {
          "transition": "R-GemOx",
          "distribution": 0.2
        },
        {
          "transition": "R-ICE",
          "distribution": 0.4
        },
        {
          "transition": "R-MINE",
          "distribution": 0.005
        }
      ],
      "remarks": [
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175435/",
        "",
        "Distribution of drug regimens is based upon conversations with Dr. Wood and Dr. Perales regarding which drug lines are most commonly used in practice today."
      ]
    },
    "Non_candidates_for_Transplant": {
      "type": "Simple",
      "distributed_transition": [
        {
          "transition": "Clinical_Trial_2",
          "distribution": 0.05
        },
        {
          "transition": "Second-line Therapy Drug Regimens",
          "distribution": 0.25
        },
        {
          "transition": "Palliative Radiation",
          "distribution": 0.7
        }
      ],
      "remarks": [
        "Distribution based upon conversation with Dr. Wood and Dr. Perales"
      ]
    },
    "Brentuximab vedotin": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1147323,
          "display": "brentuximab vedotin 50 MG Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "Ibrutinib": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1442986,
          "display": "ibrutinib 140 MG Oral Capsule"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "Clinical_Trial_2": {
      "type": "Procedure",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 110465008,
          "display": "Clinical trial (procedure)"
        }
      ],
      "direct_transition": "Length_of_Non-Drug Treatment",
      "remarks": [
        "https://jnccn.org/view/journals/jnccn/17/6/article-p650.xml"
      ]
    },
    "Palliative Radiation": {
      "type": "Procedure",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 168528006,
          "display": "Palliative course of radiotherapy (procedure)"
        }
      ],
      "direct_transition": "Length_of_Non-Drug Treatment",
      "remarks": [
        "https://jnccn.org/view/journals/jnccn/17/6/article-p650.xml"
      ]
    },
    "Worsened After Treatment 2": {
      "type": "SetAttribute",
      "attribute": "Treatment_2_Outcome",
      "direct_transition": "End Post-Second-Line Check-Up Encounter",
      "value": "Worsened"
    },
    "Remission After Treatment 2": {
      "type": "SetAttribute",
      "attribute": "Treatment_2_Outcome",
      "direct_transition": "End Post-Second-Line Check-Up Encounter",
      "value": "Remission"
    },
    "Check-Up After Second Line Treatment": {
      "type": "Encounter",
      "encounter_class": "inpatient",
      "reason": "",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "1234",
          "display": "Encounter for check up (procedure)"
        }
      ],
      "direct_transition": "Blood Tests"
    },
    "Delay after Second-Line Treatment": {
      "type": "Delay",
      "direct_transition": "Check-Up After Second Line Treatment",
      "remarks": [
        "At most cancer centers, follow-up visits are scheduled every 2 to 3 months for the first 1 to 2 years after treatment is completed, which is when the risk of recurrence is highest.",
        "https://www.cancer.net/cancer-types/lymphoma-hodgkin/follow-care#:~:text=At%20most%20cancer%20centers%2C%20follow,until%205%20years%20have%20passed."
      ],
      "range": {
        "low": 2,
        "high": 3,
        "unit": "months"
      }
    },
    "Second-Line Treatment Halted Spread of Disease": {
      "type": "Observation",
      "category": "procedure",
      "unit": "",
      "codes": [
        {
          "system": "LOINC",
          "code": "88040-1",
          "display": "Response to cancer treatment"
        }
      ],
      "value_code": {
        "system": "SNOMED-CT",
        "code": 359746009,
        "display": "Patient's condition stable (finding)"
      },
      "direct_transition": "Delay after Second-Line Treatment",
      "remarks": [
        "According to Dr. Wood, if you received second line treatment and achieved remission, you donâ€™t go onto CAR-T. Wait for subsequent progression of disease and then go onto CAR-T."
      ]
    },
    "Second Line Treatment Inneffective": {
      "type": "Observation",
      "category": "procedure",
      "unit": "",
      "codes": [
        {
          "system": "LOINC",
          "code": "88040-1",
          "display": "Response to cancer treatment"
        }
      ],
      "value_code": {
        "system": "SNOMED-CT",
        "code": 271299001,
        "display": "Patient's condition worsened (finding)"
      },
      "direct_transition": "Worsened After Treatment 2"
    },
    "Blood Tests": {
      "type": "Procedure",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": 396550006,
          "display": "Blood test (procedure)"
        }
      ],
      "duration": {
        "low": 10,
        "high": 15,
        "unit": "minutes"
      },
      "remarks": [
        "According to Dr. Perales, around half of patients go into full remission after first-line therapy, and about another half go into full remission after second-line therapy."
      ],
      "complex_transition": [
        {
          "condition": {
            "condition_type": "Attribute",
            "attribute": "DLBCL_Survival",
            "operator": "==",
            "value": "No"
          },
          "distributions": [
            {
              "transition": "Patient Relapses",
              "distribution": 1
            }
          ]
        },
        {
          "distributions": [
            {
              "transition": "Second-Line Therapy Shown to be Effective",
              "distribution": 0.5
            },
            {
              "transition": "Patient Relapses",
              "distribution": 0.5
            }
          ],
          "condition": {
            "condition_type": "Attribute",
            "attribute": "DLBCL_Survival",
            "operator": "==",
            "value": "Yes"
          }
        }
      ]
    },
    "Patient Relapses": {
      "type": "Observation",
      "category": "vital-signs",
      "unit": "",
      "codes": [
        {
          "system": "LOINC",
          "code": "88040-1",
          "display": "Response to cancer treatment"
        }
      ],
      "direct_transition": "Worsened After Treatment 2",
      "value_code": {
        "system": "SNOMED-CT",
        "code": 271299001,
        "display": "Patient's condition worsened (finding)"
      }
    },
    "Second-Line Therapy Shown to be Effective": {
      "type": "Observation",
      "category": "laboratory",
      "unit": "",
      "codes": [
        {
          "system": "LOINC",
          "code": "88040-1",
          "display": "Response to cancer treatment"
        }
      ],
      "direct_transition": "Remission After Treatment 2",
      "value_code": {
        "system": "SNOMED-CT",
        "code": 268910001,
        "display": "Patient condition improved (finding)"
      }
    },
    "Second-line Therapy Drug Regimens": {
      "type": "Simple",
      "distributed_transition": [
        {
          "transition": "Brentuximab vedotin",
          "distribution": 0.3
        },
        {
          "transition": "Bendamustine+Rituximab",
          "distribution": 0.04
        },
        {
          "transition": "Gemcitabine+Rituximab",
          "distribution": 0.18
        },
        {
          "transition": "Lenalidomide+Rituximab",
          "distribution": 0.18
        },
        {
          "transition": "Ibrutinib",
          "distribution": 0.3
        }
      ],
      "remarks": [
        "https://jnccn.org/view/journals/jnccn/14/2/article-p196.xml",
        "https://jnccn.org/view/journals/jnccn/17/6/article-p650.xml",
        "Distribution based upon conversation with Dr. Wood."
      ]
    },
    "Length_of_Non-Drug Treatment": {
      "type": "Delay",
      "direct_transition": "End Second Line Treatment Encounter",
      "range": {
        "low": 9,
        "high": 18,
        "unit": "weeks"
      }
    },
    "End Second Line Drug Treatment": {
      "type": "MedicationEnd",
      "direct_transition": "End Second Line Treatment Encounter",
      "referenced_by_attribute": "second_line_drug_regimen"
    },
    "Length of Drug Treatment - Transplant": {
      "type": "Delay",
      "direct_transition": "End Second Line Drug Treatment",
      "range": {
        "low": 9,
        "high": 18,
        "unit": "weeks"
      }
    },
    "End Post-Second-Line Check-Up Encounter": {
      "type": "EncounterEnd",
      "direct_transition": "Terminal"
    },
    "Lenalidomide+Rituximab": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 602910,
          "display": "lenalidomide 10 MG Oral Capsule"
        },
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "Bendamustine+Rituximab": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 1805001,
          "display": "bendamustine hydrochloride 100 MG Injection"
        },
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    },
    "Gemcitabine+Rituximab": {
      "type": "MedicationOrder",
      "codes": [
        {
          "system": "RxNorm",
          "code": 2058858,
          "display": "120 ML gemcitabine 10 MG/ML Injection"
        },
        {
          "system": "RxNorm",
          "code": 1657862,
          "display": "10 ML rituximab 10 MG/ML Injection"
        }
      ],
      "direct_transition": "Length of Drug Treatment - Transplant",
      "assign_to_attribute": "second_line_drug_regimen"
    }
  }
}